Inactive Instrument

Generex Biotechnology Corporation Share Price OTC Bulletin Board

Equities

US3714851033

Biotechnology & Medical Research

End-of-day quote OTC Bulletin Board
- USD - Intraday chart for Generex Biotechnology Corporation
Managers TitleAgeSince
Chief Executive Officer 61 21/17/21
Director of Finance/CFO - 01/17/01
Chief Operating Officer 65 25/18/25
Members of the board TitleAgeSince
Director/Board Member 63 01/04/01
Corporate Officer/Principal 66 01/05/01
Director/Board Member 57 21/17/21
More insiders
Generex Biotechnology Corporation is a life science holding company. The Company is engaged in pharmaceutical and biotechnological research and development and other activities. It is focused on building an organizational platform for the financing, development, commercialization and distribution of promising devices, biologics, therapeutic and diagnostic products to improve human health. The Company's subsidiary includes NuGenerex family of companies: NuGenerex Immuno-Oncology, Inc., NuGenerex Diagnostics, NuGenerex Health, LLC, NuGenerex Regenerative Medicine (NRM), NuGenerex Diagnostics (NGD), and NuGenerex Therapeutics. NuGenerex Immuno-Oncology, Inc. is a platform biotechnology company focused on improving the innate immune system to treat and prevent cancer and infectious disease with a pipeline of immunotherapy indications based on its patented platform technology.
More about the company